# Question

The requested held-out target list contains one perturbation:

```text
Six6
```

For this target I need to predict `n_degs`, the number of measured genes with
Benjamini-Hochberg-adjusted Wilcoxon `pvals_adj < 0.05` in the focal cell group
`151 TH Prkcd Grin2c Glut`, after acute sparse postnatal CRISPR loss of
function in mouse neurons.

I treated `151 TH Prkcd Grin2c Glut` as an Allen thalamic glutamatergic class,
not as tyrosine-hydroxylase-positive cells. A predicted zero means no measured
gene is expected to pass the specific FDR threshold in this assay; it does not
mean Six6 is unimportant in every cell type or in development.

# Sources Used

Internal same-experiment sources:

- `151_TH_Prkcd_Grin2c_Glut_deg_counts_training.csv`: observed focal-cell
  `n_degs` for 1,674 non-held-out perturbations.
- `training_de_all_cell_groups.parquet`: per-gene log fold changes and
  Wilcoxon p-values for the non-held-out perturbations. I filtered this table
  to `group_name == "151 TH Prkcd Grin2c Glut"` for focal-cell expression
  profiles.
- Distributed Agents corpus MCP, release
  `perturbai-july-260713-sourceguard-1773-v1`: queried with
  `target_context("Six6")`. This returned no Six6-specific same-experiment
  Claims, Findings, or explicit references, so no direct corpus prior was
  available for Six6.
- Distributed Agents runtime profile comparison:
  `six6_eye_field_compare.json`, generated over focal-cell log-fold-change
  profiles for `Six3`, `Six5`, `Pax6`, `Pax2`, `Dach1`, `Rax`, `Vsx2`, `Otx2`,
  `Notch1`, `Sox2`, and `Sox5`.

External literature:

- Jean, Bernier and Gruss 1999, DOI `10.1016/s0925-4773(99)00068-4`;
  PubMed `10473118`. Described mouse Six6/Optx2 as a Six3-related homeobox
  gene expressed in the presumptive pituitary/hypothalamic axis, ventral optic
  stalk, and ventral neural retina.
- Toy and Sundin 1999, DOI `10.1016/s0925-4773(99)00049-0`;
  PubMed `10381579`. Reported Optx2/Six6 in anterior neural plate, optic
  vesicle, ventral forebrain, later optic chiasm, pituitary primordia, and
  adult retina.
- Li et al. 2002, DOI `10.1126/science.1073263`; PubMed `12130660`.
  Showed Six6 with Dach corepressors regulates retinal and pituitary precursor
  proliferation by repressing cyclin-dependent kinase inhibitors including
  p27/Kip1.
- Lopez-Rios et al. 2003, DOI `10.1242/dev.00185`; PubMed `12441302`.
  Showed SIX3/SIX6 can interact with Groucho-family corepressors and act in an
  eye-development network.
- VanDunk, Hunter and Gray 2011, DOI `10.1523/JNEUROSCI.5385-10.2011`;
  PubMed `21525287`. Found Six3/Six6/Fzd5/Rx expression in the
  suprachiasmatic nucleus developmental field and showed Six3 is required for
  SCN formation.
- Clark et al. 2013, DOI `10.1177/0748730412468084`; PubMed `23382588`.
  Showed Six6-null mice have abnormal circadian behavior and lack
  histochemically defined SCN markers.
- Ferran, Puelles and Rubenstein 2015, DOI `10.3389/fnana.2015.00046`;
  PubMed `25941476`. Used the Allen Developing Mouse Brain Atlas to identify
  Six6 as an acroterminal-domain marker in embryonic hypothalamus.
- Diacou et al. 2018, DOI `10.1016/j.celrep.2018.10.106`;
  PubMed `30485816`, and Ferrena et al. 2024,
  DOI `10.1371/journal.pone.0308839`; PubMed `39446806`. Showed Six3 and
  Six6 jointly maintain multipotent neuroretinal progenitors and regulate FGF,
  Wnt/beta-catenin, and retinogenic programs.
- Larder et al. 2011, DOI `10.1523/JNEUROSCI.1688-10.2011`;
  PubMed `21228153`, and Pandolfi et al. 2019,
  DOI `10.1210/en.2019-00113`; PubMed `31211355`. Showed Six6 has essential
  roles in the hypothalamic GnRH system and fertility.

# Dataset Computations

1. I loaded the requested-target CSV and verified that the only held-out target
   in this run is `Six6`.

2. I loaded the focal-cell training DEG counts. The distribution is very sparse:
   1,205/1,674 training targets have `n_degs == 0`, 363 have 1-9 DEGs, 63 have
   10-99, and 43 have at least 100. The median across all training targets is
   zero and the median among nonzero targets is one.

3. I searched the training-count table for Six-family and eye-field or
   hypothalamic/pituitary developmental genes that were assayed as
   non-held-out perturbations in the focal cell group. The most relevant
   observed counts were:

   | training perturbation | focal-cell `n_degs` |
   | --- | ---: |
   | `Six3` | 0 |
   | `Six5` | 0 |
   | `Dach1` | 0 |
   | `Pax6` | 0 |
   | `Pax2` | 0 |
   | `Rax` | 0 |
   | `Vsx2` | 0 |
   | `Otx2` | 0 |
   | `Notch1` | 0 |
   | `Lhx3` | 0 |
   | `Lhx4` | 0 |
   | `Neurod1` | 0 |
   | `Neurod2` | 0 |
   | `Cdkn2a` | 0 |
   | `Sox2` | 2 |
   | `Sox5` | 2 |
   | `Peg3` | 1 |

   This group of developmental regulators is overwhelmingly zero or one-to-two
   DEGs in `151 TH Prkcd Grin2c Glut`.

4. I filtered the DE Parquet to the focal cell group and to the same
   mechanistic comparators. Each comparator had 17,259 tested measured genes.
   `Six3`, `Six5`, `Dach1`, `Pax6`, `Pax2`, `Rax`, `Vsx2`, `Otx2`, `Notch1`,
   `Lhx3`, and `Lhx4` had no adjusted p-value below 0.05. Their leading
   nominal hits were small isolated genes that did not survive BH correction:
   `Six3`, `Six5`, `Pax6`, `Dach1`, and `Vsx2` all had minimum adjusted p-value
   equal to 1.0; `Rax` reached only 0.649; `Otx2` reached only 0.885.
   `Sox2` had exactly two significant down genes (`Tnnt1`, `Stam`), and `Sox5`
   had exactly two significant up genes (`Dgkh`, `Tnnt1`).

5. I ran a Distributed Agents runtime profile comparison over these focal-cell
   log-fold-change signatures with `logfoldchanges` as the signed value,
   measured gene symbols as features, and `pvals_adj < 0.05` as the
   significance threshold. The runtime classified 9/11 reviewed eye-field
   profiles as `no_significant_features`; only `Sox2` and `Sox5` were in the
   `1_to_9_significant_features` bucket. Whole-profile correlations among
   the quiet profiles were moderately positive but shared no significant genes,
   confirming that the similarity is a low-level noise/background pattern, not
   a coherent significant Six/retinal response in the thalamic class.

# Target-Specific Reasoning

## Six6

Most relevant within-dataset analogs:

| analog | observed `n_degs` | expression-pattern evidence | relevance to Six6 |
| --- | ---: | --- | --- |
| `Six3` | 0 | 17,259 focal genes tested; no `pvals_adj < 0.05`; minimum adjusted p-value rounded to 1.0 | Closest assayed Six6 paralog in the SIX3/SIX6 homeobox subfamily; shares the embryonic eye-field and ventral forebrain program, and Six3/Six6 double perturbation is stronger than either single perturbation in retinal progenitors. |
| `Six5` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value rounded to 1.0 | Same broad SIX family but a weaker analog than Six3 because it belongs to a different subfamily and is not the canonical ventral retina/hypothalamus Six6 partner; useful mainly as a counterexample against treating SIX-family membership alone as a reason for a broad effect. |
| `Dach1` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value rounded to 1.0 | DACH proteins can act with SIX factors as transcriptional corepressors in the retinal/pituitary progenitor proliferation program; its focal-cell null argues that the embryonic Six-Dach module is not active enough here to generate a broad signature. |
| `Pax6` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value rounded to 1.0 | Eye-field and retinal progenitor regulator that can cooperate upstream of Six6 in retinal development; inappropriate as a direct paralog but a good developmental-domain comparator. |
| `Rax` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value 0.649 | Early eye-field and anterior hypothalamic marker, closer to the tissue program in which Six6 is expressed than to mature thalamic maintenance. |
| `Vsx2` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value rounded to 1.0 | Neural-retina progenitor transcription factor; useful because the Six6 retinal phenotype is progenitor/retina centered. |
| `Otx2` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value 0.885 | Eye-field/optic and hypothalamic developmental regulator and ATD marker adjacent to Six6 in embryonic patterning evidence. |
| `Sox2` | 2 | Two significant downregulated genes among 17,259 | More ubiquitous progenitor/stem regulator in the eye-field network; included as an upper-bound weak analog because it is broader than Six6 yet still produces only two focal DEGs. |
| `Notch1` | 0 | 17,259 tested; no `pvals_adj < 0.05`; minimum adjusted p-value rounded to 1.0 | Retinal progenitor maintenance pathway counterexample; close to the progenitor context, but not a Six6-specific postmitotic thalamic regulator. |

The external biology points in the same direction as the training data. Six6 is
a homeobox transcription factor with strong developmental roles in the ventral
optic stalk, neural retina, pituitary/hypothalamic axis, GnRH neurons, and
suprachiasmatic nucleus. Those roles are real, but they are spatially and
developmentally concentrated. The perturbation being predicted here is not an
embryonic retinal or pituitary knockout: it is an AAV CRISPR loss of function
delivered at P16 and read out at P37-P44 in recovered NeuN-positive nuclei.

The focal class is thalamic glutamatergic. That makes the retinal progenitor
Six3/Six6-Dach-p27 mechanism, the FGF/Wnt balance in embryonic eye cups, and
the GnRH/SCN phenotypes imperfect templates. If acute Six6 loss were hitting
the same regulatory program in this class, at least the direct paralog `Six3`
or eye-field comparators such as `Pax6`, `Rax`, `Vsx2`, `Otx2`, or `Dach1`
would be expected to show some BH-significant footprint under the same assay.
Instead they are all exact zeros. Even `Sox2`, a much broader developmental
factor, gives only two DEGs.

There are broad Wnt and cell-cycle perturbations in the training set with
larger focal responses, for example `Ctnnb1` with 383 DEGs and `Cdk13` with 56
DEGs, but these are counterexamples rather than analogs. Six6 can influence
Wnt signaling and progenitor proliferation in embryonic retinal cells, but
acute loss of the Six6 transcription factor in postmitotic thalamic neurons is
not equivalent to disrupting beta-catenin or a general transcriptional CDK.

I therefore predict that `Six6` lands with its nearest assayed family and
eye-field analogs at zero focal-cell DEGs.

Final point prediction:

```text
Six6 -> 0
```

# Limits

- Six6 itself was completely held out, and the same-experiment Distributed Agents corpus
  had no Six6-specific Claims or Findings. The prediction is an extrapolation
  from paralogs and pathway neighbors rather than a same-target signature.
- The Parquet has differential-expression summaries but not raw counts or
  baseline expression by nucleus, so I did not directly test whether Six6 RNA
  is absent from this focal class.
- The strongest Six6 literature concerns embryonic retina, pituitary,
  hypothalamic GnRH neurons, and SCN development. These are not the same cells
  or developmental window as P16-to-P37/P44 thalamic glutamatergic neurons.
- A zero count is a thresholded assay prediction. It would still be compatible
  with a subtle effect, a rare Six6-positive subpopulation below the power of
  this grouped test, or a phenotype outside the snRNA-seq DEG endpoint.
